April 23 - 25, 2018

Media Center

Download the 2018 Agenda!

Intelligent automation is providing pharma and biotech companies, and their contract manufacturing partners, major gains with minimized risk compared to previous waves of automation. Download the agenda to view how you can tackle the following challenges this April!

  • Identify the role of intelligent automation in pharma and biotech manufacturin
  • Explore how RPA can flexibly automate processes without requiring constant internal IT support
  • Discuss how to leverage the data being collected at every stage of the manufacturing process
  • Build a more agile framework for supporting small batch orders, including clinical trials, rare disease treatments, and personalized medicine
  • Learn what to look for in a manufacturing partner to realize the gains from intelligent automation

If you would like to have a copy sent to you directly please request one here.

Justify Your Attendance

2018 IA in Pharma Anticipated Attendee Snapshot

Find out who you can expect to meet and learn from this April 23-25 in Boston at the 2018 Intelligent Automation in Pharma event!

To request our attendee snashot via email, contact us at enquiry@iqpc.com with "Please send me the 2018 IA in Pharma Anticipated Attendee Snapshot" in the subject line. 

Customizable Dear Boss Letter

Accelerate the approval process with our Dear Boss Letter!

2018 IA in Pharma Registration Packet

Your one-stop-shop for justifying your attendance to the 2018 IA in Pharma event! Packet includes:

  • Anticipated Attendee Snapshot
  • Justification Letter
  • Registration Form


Intelligent Automation: The Next Horizon of Pharmaceutical Innovation

This short 2018 IA in Pharma Market Snapshot provides a quick overview of how life sciences companies are leveraging AI, IoT and machine learning to revolutionize drug discovery, regulatory reporting, operational efficiency and more! Whether you've been applying IA to pharma processes for years or are brand new to the concept, check out this Industry Report At-A-Glance to see how you stack up against your peers!

Prefer to receive this content piece via email? Contact us at enquiry@iqpc.com with "Content Request 27595.001 - Intelligent Automation: The Next Horizon of Pharmaceutical Innovation" in the subject line.

Articles and Whitepapers

AI 2020: The Future of Drug Discovery

Drug development approaches a fascinating era as the trend of digitalization introduces sophisticated technologies which can neutralize costly hazards faced in R&D pipelines, according to a new deep-dive report by Pharma IQ.

Intelligent enterprise technologies. including the likes of artificial intelligence and machine learning, are set to transform the pharmaceutical industry enabling better healthcare and drug discovery processes.

Almost 100 drug discovery practitioners from around the globe – including experts from leading companies such as Pfizer, Sanofi, Novartis, AstraZeneca and GSK – took part in our in-depth research. Key topics covered include:

  •     The IE applications that will have the most impact on businesses by 2020
  •     What stage businesses are on their AI journey and where they want to be by 2020
  •     The biggest challenges faced by organizations implementing IE and what can be done to overcome them
  •     Business readiness for investment in AI
  •     How IE technologies might impact pharma’s R&D phases
  •     Strategies for implementation
  •     And much more

Download this report for its exclusive insights on the challenges, opportunities and potential impact intelligent enterprise technologies will bring to the industry.

Five ways AI is Reshaping the Biomedical Industry

When we sat down with Professor Jackie Hunter, CEO of BelevolentBio, to discuss the untapped potential of AI and how the technology is helping to close the industry’s information-innovation gap…

Top 10 Pharma and Biotech Trends to Watch in 2018

Pharma IQ takes a look at some of the trends forecasted to take hold this year: disruption for vendor landscapes, regulatory intervention and sophisticated analytics technologies gaining speed.

Muyinatu Bell Shares Top Recommendations for Implementing Artificial Intelligence & Machine Learning Solutions

In this keynote speaker spotlight, Muyinatu Bell shares her top recommendations for healthcare innovators implementing artificial intelligence and machine learning solutions. She also shares her thoughts on being selected by MIT Technology Review as one of 35 Innovators Under 35 in 2016, her thoughts on the next generation of healthcare, how intelligent automation technologies helped inspire her to develop innovative biomedical solutions, and what she hopes attendees will learn from her keynote session.

Leveraging RPA for the Business via Outsourcing Collaboration by Shuchita Singh, Director - Outsourcing Governance, AbbVie

An enterprise-wide Intelligent Automation CoE is an effective way to roll-out automation across various business lines, but the absence of such a central function requires creative approaches to harness automation. Through this Case Study, we will discuss:

  • Why RPA was required to advance business function
  • What was the optimal approach in the absence of a fully-functional Intelligent Automation CoE
  • How to leverage third-party relationships to advance the approach


#RPAgoals with Eli Lilly's Director of Automation COE, Finance Shared Service Center

We recently sat down with Matt Gustitus, the Director - Automation COE, Finance Shared Service Center at Eli Lilly and Company, to discuss how his company is embracing RPA, where his company is on their intelligent automation (IA) journey, their top 3 priorities for the next year and more!